Stephen F. Betz insider trades: Crinetics Pharmaceuticals (CRNX) stock sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Stephen reports to the SEC
Open-market buys and sales
49 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | CRNX | ↓ Sell | 10,612 | $37.37 | $397K | Direct | Mar 18, 2026 (2d) |
| Jun 12, 2025 | CRNX | ↓ Sell | 97,483 | $32.23 | $3.1M | Direct | Jun 16, 2025 (4d) |
| Mar 19, 2025 | CRNX | ↓ Sell | 5,770 | $34.20 | $197K | Direct | Mar 21, 2025 (2d) |
| Sep 10, 2024 | CRNX | ↓ Sell | 1,035 | $51.50 | $53K | Direct | Sep 12, 2024 (2d) |
| Aug 26, 2024 | CRNX | ↓ Sell | 3,000 | $53.19 | $160K | Direct | Aug 28, 2024 (2d) |
| Aug 12, 2024 | CRNX | ↓ Sell | 3,000 | $47.68 | $143K | Direct | Aug 14, 2024 (2d) |
| Jul 25, 2024 | CRNX | ↓ Sell | 3,000 | $53.43 | $160K | Direct | Jul 26, 2024 (1d) |
| Jul 10, 2024 | CRNX | ↓ Sell | 3,000 | $48.55 | $146K | Direct | Jul 12, 2024 (2d) |
| Jun 25, 2024 | CRNX | ↓ Sell | 3,000 | $45.37 | $136K | Direct | Jun 26, 2024 (1d) |
| Jun 10, 2024 | CRNX | ↓ Sell | 3,000 | $43.86 | $132K | Direct | Jun 11, 2024 (1d) |
| May 28, 2024 | CRNX | ↓ Sell | 3,000 | $47.49 | $142K | Direct | May 30, 2024 (2d) |
| May 10, 2024 | CRNX | ↓ Sell | 3,000 | $49.43 | $148K | Direct | May 14, 2024 (4d) |
| Jan 25, 2024 | CRNX | ↓ Sell | 3,000 | $37.26 | $112K | Direct | Jan 26, 2024 (1d) |
| Jan 10, 2024 | CRNX | ↓ Sell | 3,000 | $37.65 | $113K | Direct | Jan 12, 2024 (2d) |
| Dec 26, 2023 | CRNX | ↓ Sell | 3,000 | $35.89 | $108K | Direct | Dec 27, 2023 (1d) |
| Dec 11, 2023 | CRNX | ↓ Sell | 3,000 | $32.87 | $99K | Direct | Dec 13, 2023 (2d) |
| Nov 27, 2023 | CRNX | ↓ Sell | 3,000 | $31.84 | $96K | Direct | Nov 29, 2023 (2d) |
| Feb 1, 2023 | CRNX | ↓ Sell | 3,126 | $19.59 | $61K | Direct | Feb 3, 2023 (2d) |
| Jan 25, 2023 | CRNX | ↓ Sell | 8,336 | $21.07 | $176K | Direct | Jan 27, 2023 (2d) |
| Jan 17, 2023 | CRNX | ↓ Sell | 3,126 | $18.00 | $56K | Direct | Jan 19, 2023 (2d) |
| Jan 3, 2023 | CRNX | ↓ Sell | 3,126 | $18.35 | $57K | Direct | Jan 5, 2023 (2d) |
| Dec 15, 2022 | CRNX | ↓ Sell | 3,126 | $16.00 | $50K | Direct | Dec 19, 2022 (4d) |
| Dec 1, 2022 | CRNX | ↓ Sell | 3,126 | $17.84 | $56K | Direct | Dec 5, 2022 (4d) |
| Nov 15, 2022 | CRNX | ↓ Sell | 3,126 | $18.72 | $59K | Direct | Nov 17, 2022 (2d) |
| Nov 1, 2022 | CRNX | ↓ Sell | 3,126 | $18.52 | $58K | Direct | Nov 3, 2022 (2d) |
| Oct 17, 2022 | CRNX | ↓ Sell | 3,126 | $17.73 | $55K | Direct | Oct 19, 2022 (2d) |
| Oct 3, 2022 | CRNX | ↓ Sell | 3,126 | $19.64 | $61K | Direct | Oct 5, 2022 (2d) |
| Sep 15, 2022 | CRNX | ↓ Sell | 4,168 | $21.01 | $88K | Direct | Sep 19, 2022 (4d) |
| Sep 7, 2022 | CRNX | ↓ Sell | 1,042 | $21.00 | $22K | Direct | Sep 9, 2022 (2d) |
| Sep 1, 2022 | CRNX | ↓ Sell | 3,126 | $18.59 | $58K | Direct | Sep 6, 2022 (5d) |
| May 2, 2022 | CRNX | ↓ Sell | 3,247 | $20.10 | $65K | Direct | May 4, 2022 (2d) |
| Apr 18, 2022 | CRNX | ↓ Sell | 5,664 | $25.81 | $146K | Direct | Apr 21, 2022 (3d) |
| Apr 4, 2022 | CRNX | ↓ Sell | 9,000 | $23.97 | $216K | Direct | Apr 6, 2022 (2d) |
| Apr 1, 2022 | CRNX | ↓ Sell | 8,328 | $21.43 | $178K | Direct | Apr 1, 2022 (0d) |
| Mar 15, 2022 | CRNX | ↓ Sell | 3,123 | $18.94 | $59K | Direct | Mar 17, 2022 (2d) |
| Mar 1, 2022 | CRNX | ↓ Sell | 3,123 | $19.73 | $62K | Direct | Mar 2, 2022 (1d) |
| Feb 15, 2022 | CRNX | ↓ Sell | 3,123 | $18.64 | $58K | Direct | Feb 17, 2022 (2d) |
| Feb 1, 2022 | CRNX | ↓ Sell | 3,123 | $18.79 | $59K | Direct | Feb 3, 2022 (2d) |
| Jan 18, 2022 | CRNX | ↓ Sell | 4,168 | $23.29 | $97K | Direct | Jan 20, 2022 (2d) |
| Jan 3, 2022 | CRNX | ↓ Sell | 7,168 | $28.02 | $201K | Direct | Jan 6, 2022 (3d) |
| Dec 28, 2021 | CRNX | ↓ Sell | 3,000 | $27.95 | $84K | Direct | Dec 30, 2021 (2d) |
| Dec 15, 2021 | CRNX | ↓ Sell | 5,668 | $24.14 | $137K | Direct | Dec 17, 2021 (2d) |
| Dec 1, 2021 | CRNX | ↓ Sell | 5,668 | $27.38 | $155K | Direct | Dec 3, 2021 (2d) |
| Nov 16, 2021 | CRNX | ↓ Sell | 1,500 | $27.97 | $42K | Direct | Nov 17, 2021 (1d) |
| Nov 15, 2021 | CRNX | ↓ Sell | 5,668 | $26.75 | $152K | Direct | Nov 17, 2021 (2d) |
| Nov 8, 2021 | CRNX | ↓ Sell | 16,500 | $28.06 | $463K | Direct | Nov 9, 2021 (1d) |
| Nov 1, 2021 | CRNX | ↓ Sell | 5,668 | $24.79 | $141K | Direct | Nov 3, 2021 (2d) |
| Oct 27, 2021 | CRNX | ↓ Sell | 3,000 | $24.00 | $72K | Direct | Oct 28, 2021 (1d) |
| Oct 21, 2021 | CRNX | ↓ Sell | 1,042 | $21.10 | $22K | Direct | Oct 25, 2021 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other CRNX insiders
Open-market trades in the last 12 months
About Stephen F. Betz's insider trades
Stephen F. Betz is Chief Scientific Officer at Crinetics Pharmaceuticals (CRNX). Since Oct 21, 2021, Stephen has reported no open-market purchases and 49 sales worth $8.7M on SEC Form 4. In the last 12 months: 1 sale ($397K).
Their filings also include grants and awards (5 filings), option exercises (2 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every CRNX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.